Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor de Ledinghen

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|March 5, 2022
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver diseaseGrazia Pennisi, Rosaria Maria Pipitone, Daniela Cabibi, et al.
Journal of Hepatology|March 15, 2012
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirinDominique Larrey, Ansgar W Lohse, Victor de Ledinghen, et al.
European Journal of Clinical Pharmacology|August 7, 2019
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohortAurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, et al.
Viruses|January 21, 2023
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?Lucy Meunier, Mohamed Belkacemi, George Philippe Pageaux, et al.
Journal of Hepatology|December 3, 2014
Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trialThierry Thévenot, Christophe Bureau, Frédéric Oberti, et al.
Journal of Hepatology|August 10, 2018
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosisNathalie Ganne-Carrié, Cendrine Chaffaut, Valérie Bourcier, et al.
Clinics and Research in Hepatology and Gastroenterology|June 30, 2020
Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohortAnais Vallet-Pichard, Jean-Michel Correas, Celine Dorival, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2018
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver DiseaseZobair M Younossi, Maria Stepanova, Janus Ong, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2021
CorrigendumStanislas Pol, Clovis Luzivika Nzinga, Céline Dorival, et al.
Journal of Hepatology|July 26, 2011
Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 studyJean-Pierre Zarski, Nathalie Sturm, Jérôme Guechot, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Liver International : Official Journal of the International Association for the Study of the Liver|March 5, 2022
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver diseaseGrazia Pennisi, Rosaria Maria Pipitone, Daniela Cabibi, et al.
Journal of Hepatology|March 15, 2012
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirinDominique Larrey, Ansgar W Lohse, Victor de Ledinghen, et al.
European Journal of Clinical Pharmacology|August 7, 2019
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohortAurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, et al.
Viruses|January 21, 2023
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?Lucy Meunier, Mohamed Belkacemi, George Philippe Pageaux, et al.
Journal of Hepatology|December 3, 2014
Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trialThierry Thévenot, Christophe Bureau, Frédéric Oberti, et al.
Journal of Hepatology|August 10, 2018
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosisNathalie Ganne-Carrié, Cendrine Chaffaut, Valérie Bourcier, et al.
Clinics and Research in Hepatology and Gastroenterology|June 30, 2020
Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohortAnais Vallet-Pichard, Jean-Michel Correas, Celine Dorival, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2018
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver DiseaseZobair M Younossi, Maria Stepanova, Janus Ong, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2021
CorrigendumStanislas Pol, Clovis Luzivika Nzinga, Céline Dorival, et al.
Journal of Hepatology|July 26, 2011
Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 studyJean-Pierre Zarski, Nathalie Sturm, Jérôme Guechot, et al.
Pageof 18